TCF
LIVE

Serial Number

79152345

Owner

Dirk Busch

Attorney

Cynthia Smuzynska

Filing Date

Jun 13, 2014

Add to watchlist:

No watchlists yet
View on USPTO

TCF Trademark

Serial Number: 79152345 • Registration: 4903231

TCF is a trademark filed by Dirk Busch on June 13, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Dirk Busch

Havelstr. 6 A

Entity Type: 01

Kite Pharma, Inc. (157 trademarks)

2400 Broadway

Entity Type: 99

Kite Pharma EU B.V. (3 trademarks)

NL-1098 XH Amsterdam , NL

Entity Type: 99

Trademark Details

Filing Date

June 13, 2014

Registration Date

February 23, 2016

Published for Opposition

December 8, 2015

Goods & Services

[ chemical preparations for industrial and scientific use, namely, polypeptides and proteins made by genetic engineering, including fusion proteins as well as nucleic acids encoding these polypeptides and proteins, namely, body cells and cells of the immune system of mammals, including human cells; analytical kits consisting of chemical reagents for industrial and scientific use, for the purification, detection and immobilization of fusion proteins, fusion peptides and cells, namely, body cells and cells of the immune system of mammals, including human cells; diagnostic preparations except for medical purposes ]

pharmaceutical [ and veterinary ] preparations for the treatment of cancer, including hematologic cancers, [ viral mediated diseases, bacterial mediated diseases, and inflammatory and autoimmune diseases, including rheumatoid arthritis, osteoarthritis, Crohn's disease, psoriasis, psoriatic arthritis, ], namely, polypeptides and proteins made by genetic engineering, including fusion proteins, cells, namely, body cells and cells of the immune system of mammals, including human cells [ ; diagnostic preparations for medical purposes ]

[ Scientific and industrial research in the field of biochemistry, diagnostics and pharmaceutics; biochemical or pharmaceutical laboratory services, namely, synthesis of recombinant polypeptides and proteins, cultivation and purification of cells, namely, of body cells and cells of the immune system of mammals including human cells ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Dec 22, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Dec 22, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 2, 2025 APRE
TEAS SECTION 71 RECEIVED
Aug 1, 2025 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Feb 23, 2025 REM4
INTERNATIONAL REGISTRATION RENEWED
Mar 15, 2024 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Sep 11, 2023 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jul 23, 2023 INPS
INVALIDATION PROCESSED
Jul 23, 2023 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 19, 2023 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Oct 19, 2022 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Oct 19, 2022 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 19, 2022 APRE
CHANGE OF OWNER RECEIVED FROM IB
Feb 18, 2022 CHLD
TEAS SECTION 71 & 15 RECEIVED
Feb 15, 2022 ES75
NEW REPRESENTATIVE AT IB RECEIVED
Dec 4, 2021 NREP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 19, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 19, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 19, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 19, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 19, 2021 COAR
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 23, 2021 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 15, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 25, 2016 FICS
FINAL DISPOSITION PROCESSED
May 25, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 23, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 23, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 8, 2015 NPUB
PUBLISHED FOR OPPOSITION
Dec 8, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Dec 4, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 18, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 18, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 18, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 2, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 21, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 17, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 16, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 16, 2015 TROA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 30, 2015 ADCH
CHANGE OF OWNER RECEIVED FROM IB
May 14, 2015 CHLD
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 16, 2015 GNRN
NON-FINAL ACTION E-MAILED
Apr 16, 2015 GNRT
NON-FINAL ACTION WRITTEN
Apr 16, 2015 CNRT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 9, 2015 CHAN
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2015 TEME
ASSIGNED TO LIE
Apr 9, 2015 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 6, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 6, 2015 TROA
REFUSAL PROCESSED BY IB
Oct 24, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 8, 2014 RFCS
REFUSAL PROCESSED BY MPU
Oct 8, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 8, 2014 RFCR
NON-FINAL ACTION WRITTEN
Oct 7, 2014 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 4, 2014 MAFR
ASSIGNED TO EXAMINER
Sep 30, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 30, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 25, 2014 REPR